Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Current Liabilities (2016 - 2025)

Conmed (CNMD) has disclosed Total Current Liabilities for 16 consecutive years, with $315.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 13.27% year-over-year to $315.0 million, compared with a TTM value of $315.0 million through Dec 2025, up 13.27%, and an annual FY2025 reading of $315.0 million, up 13.27% over the prior year.
  • Total Current Liabilities was $315.0 million for Q4 2025 at Conmed, roughly flat from $314.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $376.3 million in Q3 2023 and bottomed at $182.2 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $267.1 million, with a median of $282.7 million recorded in 2024.
  • The sharpest move saw Total Current Liabilities skyrocketed 80.42% in 2023, then decreased 24.98% in 2024.
  • Year by year, Total Current Liabilities stood at $196.6 million in 2021, then surged by 50.8% to $296.6 million in 2022, then rose by 4.78% to $310.7 million in 2023, then dropped by 10.49% to $278.1 million in 2024, then grew by 13.27% to $315.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for CNMD at $315.0 million in Q4 2025, $314.7 million in Q3 2025, and $294.8 million in Q2 2025.